XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reclassifications, Share based Compensation, Earnings per Common Share, Share Repurchase Program & Restricted Cash (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Nov. 30, 2010
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Aug. 31, 2018
Jan. 01, 2018
Dec. 31, 2017
May 31, 2017
Retained Earnings   $ 5,632   $ 5,632       $ 3,889 [1]  
Equity Appreciation Rights Plan                  
Shares granted (in units)     0            
Restricted Cash                  
Outstanding letters of credit   0   0          
August 2017, Share Repurchase Program                  
Share Repurchase Program                  
Share repurchase program authorized amount   $ 250   $ 250          
Stock repurchased in open market transactions (in shares)   2,277 4,824 55,199 4,824        
Stock repurchased in open market transactions   $ 8 $ 16,909 $ 200 $ 16,909        
August 2018, Share Repurchase Program                  
Share Repurchase Program                  
Share repurchase program authorized amount           $ 250      
Stock repurchased in open market transactions (in shares)   8,640   8,640          
Stock repurchased in open market transactions   $ 35   $ 35          
Authorized balance remaining under share repurchase program   215   215          
ASU 2014-09                  
Retained Earnings   $ 5,632   $ 5,632     $ 1,381    
Stock Options                  
Options                  
Balance at the beginning of the period(in shares)       187,750          
Granted (in shares)   0   134,000          
Cancelled (in shares)       (3,000)          
Balance at the end of the period (in shares)   318,750   318,750          
Exercisable at the end of the period (in shares)   87,750   87,750          
Weighted-Average Exercise Price Per Share                  
Outstanding at the beginning of the period (in dollars per share)       $ 3.70          
Granted (in dollars per share)       3.36          
Cancelled (in dollars per share)       3.29          
Outstanding at the end of the period (in dollars per share)   $ 3.62   3.62          
Exercisable at the end of the period (in dollars per share)   $ 4.00   $ 4.00          
Weighted- Average Remaining Contractual Term (in years)                  
Outstanding at the end of the period       8 years 3 months 7 days          
Exercisable at the end of the period       5 years 11 months 19 days          
Aggregate Intrinsic Value                  
Outstanding at the end of the period   $ 210   $ 210          
Exercisable at the end of the period   54   54          
Additional disclosures                  
Compensation expense (income)   35 17 80 26        
Unrecognized compensation related to unvested awards   275   $ 275          
Unrecognized compensation, vesting period       3 years 3 months 11 days          
2005 Plan                  
Equity Appreciation Rights Plan                  
Shares granted (in units)       0          
2017 Plan | Stock Options                  
Additional disclosures                  
Number of common shares authorized                 350,000
2010 Plan | Equity Appreciation Rights Plan                  
Additional disclosures                  
Compensation expense (income)   $ 0 $ (4) $ 0 $ (4)        
Equity Appreciation Rights Plan                  
Vesting period from the base date 3 years                
Shares granted (in units)   0   0 100,000        
Accrued compensation   $ 0   $ 0       $ 0  
2010 Plan | Equity Appreciation Rights Plan | Maximum                  
Additional disclosures                  
Number of common shares authorized 1,000,000                
Equity Appreciation Rights Plan                  
Redemption cash payment period 90 days                
[1] The balance sheet at December 31, 2017 has been derived from the audited financial statements at that date